B7-H3 is a checkpoint molecule expressed at high levels on pediatric solid tumors including osteosarcoma [76,77], and it contributes to tumor immune evasion and metastasis, correlating with poor prognosis [78]. Here, CD276 is linked to osteosarcoma.